The latest report by IMARC Group, titled" Neurovascular Devices Market Report by Product (Cerebral Embolization and Aneurysm Coiling Devices, Cerebral Angioplasty and Stenting Systems, Neurothrombectomy Devices, Support Devices), Application (Ischemic Stroke, Aneurysm, Arteriovenous Malformation and Fistulas (AVM), Stenosis, and Others), End User (Hospitals, Ambulatory Surgical Centers, Clinics, and Others), and Region 2024-2032", offers a comprehensive analysis of the industry, which comprises insights on the market. The global neurovascular devices market size reached US$ 2.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.6 Billion by 2032, exhibiting a growth rate (CAGR) of 5.14% during 2024-2032.
Factors Affecting the Growth of the Neurovascular Devices Industry:
- Increasing Incidence of Neurovascular Diseases:
The rising incidence of neurovascular diseases, such as stroke, cerebral aneurysms, and arteriovenous malformations, is a major driver of the neurovascular devices market. With an aging global population, the prevalence of these conditions is increasing, leading to a higher demand for effective diagnostic and treatment solutions. Advances in medical technology have improved the accuracy and efficiency of neurovascular devices, making them essential tools in the management and intervention of these diseases. Additionally, increased awareness about early diagnosis and treatment options among patients and healthcare providers is further fueling the market growth, as more individuals seek timely medical attention for neurovascular conditions.
- Technological Advancements in Neurovascular Devices:
Technological advancements in neurovascular devices are significantly propelling the market forward. Innovations such as minimally invasive procedures, advanced imaging techniques, and the development of sophisticated stents, coils, and flow diversion devices have revolutionized the treatment of neurovascular diseases. These advancements have enhanced the precision, safety, and outcomes of neurovascular interventions, making them more accessible and effective for a broader patient population. Furthermore, continuous research and development efforts are leading to the introduction of new and improved devices, which offer better performance, reduced recovery times, and lower complication rates. This ongoing technological progress is a key factor driving the growth of the neurovascular devices market.
- Growing Healthcare Expenditure and Infrastructure Development:
The growing healthcare expenditure and infrastructure development across the globe are crucial drivers of the neurovascular devices market. Governments and private sectors are investing heavily in healthcare systems to improve the quality and accessibility of medical services. This includes the expansion of healthcare facilities, the adoption of advanced medical technologies, and increased funding for research and development. Improved healthcare infrastructure ensures better access to neurovascular diagnostic and treatment facilities, leading to higher adoption rates of neurovascular devices. Additionally, the rising disposable incomes and health insurance coverage in many regions enable more patients to afford advanced neurovascular treatments, further stimulating market growth.
For an in-depth analysis, you can request a sample copy of the report: https://www.imarcgroup.com/neurovascular-devices-market/requestsample
Leading Companies Operating in the Global Neurovascular Devices Market
- Acandis GmbH
- Asahi Intecc Co. Ltd.
- Imperative Care Inc.
- Integer Holdings Corporation
- Johnson & Johnson
- Medtronic plc
- MicroPort Scientific Corporation
- Penumbra Inc.
- Perflow Medical Ltd.
- Rapid Medical
- Stryker Corporation
- Terumo Corporation
Neurovascular Devices Market Report Segmentation:
By Product:
· Cerebral Embolization and Aneurysm Coiling Devices
o Embolic Coils
o Flow Diverters
o Liquid Embolic Agents
· Cerebral Angioplasty and Stenting Systems
o Carotid Artery Stents
o Embolic Protection Devices
· Neurothrombectomy Devices
o Clot Retrieval Devices
o Suction Devices
o Vascular Snares
· Support Devices
o Micro Catheters
o Micro Guidewires
Cerebral embolization and aneurysm coiling devices dominate the market as these devices are critical for treating a wide range of neurovascular conditions, offering effective minimally invasive options that are widely adopted by clinicians.
By Application:
- Ischemic Stroke
- Aneurysm
- Arteriovenous Malformation and Fistulas (AVM)
- Stenosis
- Others
Based on the application, the market has been segmented into ischemic stroke, aneurysm, arteriovenous malformation, and fistulas (AVM), stenosis, and others.
By End User:
- Hospitals
- Ambulatory Surgical Centers
- Clinics
- Others
Hospitals represent the largest segment due to their comprehensive facilities, specialized equipment, and skilled professionals necessary for performing complex neurovascular procedures.
Regional Insights:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
North America's dominance in the neurovascular devices market is attributed to advanced healthcare infrastructure, high prevalence of neurovascular disorders, and significant investment in medical research and technology.
Global Neurovascular Devices Market Trends:
The global neurovascular devices market is primarily driven by rapid shift toward minimally invasive procedures, which offer reduced recovery times and lower risks, increasing their preference among both patients and healthcare providers. Technological advancements, including the development of next-generation stent retrievers and flow diverters that enhances the efficacy and safety of neurovascular treatments is another major growth-inducing factor. Additionally, the rising prevalence of neurovascular disorders, such as strokes and aneurysms, coupled with an aging global population, is fueling demand. The market is witnessing increased investments in healthcare infrastructure and a growing emphasis on early diagnosis and preventive care, further propelling the adoption of advanced neurovascular devices worldwide.
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic, and technological developments for business leaders in pharmaceutical, industrial, and high-technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology, and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145
